Assessment Objectives

Intro to Path & Morphologic Diagnosis

  • Define pathognomonic and give an example of a pathognomonic lesion.

    • Pathognomonic: a lesion distinctive for a specific disease

    • Ex: diamond skin lesions in swine erysipelas

  • Describe the difference between gross, microscopic (histologic) and ultrastructural changes.

    • Gross: seen with the naked eye at the tissue level

    • Microscopic/histologic: seen with light microscopy at the cellular level

    • Ultrastructural: seen with electron microscopy at the organelle level

  • Define etiology and describe the difference between intrinsic and extrinsic etiologies.

    • Etiology: the cause of a lesion/disease

    • Intrinsic etiologies occur within the patient (genetics, physiology) whereas extrinsic etiologies are introduced (infections, trauma)

  • Define & give examples of etiology, pathogenesis, and morphologic changes.

    • Etiology: the cause of a lesion/disease, ex: parvovirus

    • Pathogenesis: the process by which an etiologic agent causes disease (biochemical change → functional alteration → morphologic change → clinical signs), ex: parvovirus affects puppies by infecting and killing enterocytes

    • Morphologic changes: a visible structural abnormality as the result of a pathogenesis, ex: blunted intestinal villi

  • Define and give examples of a morphologic diagnosis and an etiologic diagnosis

    • Morphologic diagnosis: states the characteristics of a lesion without implying a cause, ex: severe acute diffuse necrohemorrhagic enteritis

    • Etiologic diagnosis: states the disease process and cause, ex: Clostridial enteritis


Reversible & Irreversible Cell Injury

  • List the general causes of cell injury

    • DAMaGe

      • Disturbance in metabolism

      • ATP depletion

      • Membrane damage

      • Genetic damage

    • Double MINT

      • malformation/misc

      • infectious/immune

      • nutritional/neoplastic

      • traumatic/toxic

  • Define and give examples of dysplasia and neoplasia

    • Dysplasia:

    • Neoplasia: pathologic growth of new cells, often cancerous

  • Give examples of reversible cell injury

    • Adaptation: cells establish a new homeostatic state as a reaction to a stressor (increased functional demand, decreased nutrient supply)

      • Atrophy: reduction in cell size due to decreased supply or demand to the cell, ex: PSS → liver atrophy

      • Hypertrophy: increase in cell size via synthesis of more structural components due to increased supply or demand, ex: HCM → left ventricular hypertrophy

      • Hyperplasia: increase in number of (normal) cells due to increased demand, ex: benign prostatic hyperplasia w/age

      • Metaplasia: change in type of (fully differentiated adult) cell, ex: ciliated pseudo-stratified respiratory epithelium → stratified squamous epithelium in smokers

    • Degeneration: caused by an injurious stimulus or an inability to adapt to a stressor

      • Hydropic: cell swelling due to water accumulation in organelles or cytosol, ex: Bovine Papular Stomatitis Virus

      • Fatty change: accumulation of fat vacuoles in the cytoplasm of non-adipose cells due to increased mobilization of body fat stores, ex: hepatic lipidosis

      • Glycogen accumulation: what it sounds like, ex: in the liver

      • Myxomatous: accumulation of mucin-like material in adipose & connective tissues, ex: serous atrophy of fat

  • Outline the pathogenesis of hydropic degeneration

    • Cell injury → hypoxia → reduced ATP production & altered ion gradient → Na+ & H2O enter the cell → increased osmotic pressure in the cell → organelle & cell swelling, formation of vacuoles, & cytoskeletal disruption

  • Describe the differences between reversible and irreversible cell injury

    • Reversible cell injuries go away if the inciting cause of injury is removed, whereas irreversible cell injuries always lead to cell death.

    • A reversibly injured cell appears generally swollen with “blebbing” of plasma membranes, detachment of ribosomes from ER, & nuclear chromatin clumping. An irreversibly injured cell appears with increased cell & mitochondrial swelling, lysosome disruption, additional cell membrane disruption, & profound nuclear changes.

  • Give examples of irreversible cell injury

    • Autolysis: ex: normal post-mortem decay

    • Necrosis: ex: septic arthritis

    • Apoptosis: ex: removal of inflammatory cells post-infection

  • Describe the various types of irreversible cell injury and describe the cellular hallmarks of each type

    • Autolysis: presents with loss of tissue architectural features, separation of blood into “chicken fat” (serum) & “currant jelly” (RBC) clots unattached to vessel walls, & invasion of saprophytic intestinal bacteria (Gram + anaerobic rods w/no inflammatory response). Often presents with sharp borders & is worse in the abdominal viscera.

    • Necrosis: gross lesions are typically pale, well-demarcated with irregular contours, and may have cavitation. Early necrosis presents microscopically with cell swelling ± pallor, loss of detail, & chromatin changes in the nucleus. Later stages show hypereosinophilia (pinkness) of the cytoplasm, cell fragmentation, & inflammation. There is typically a gradient of normal→necrotic cells

  • Define apoptosis and describe how it differs from necrosis

    • Apoptosis is programmed cell death driven by the mitochondria that is under the control of the cell and occurs when cytochrome C is released. Caspase 3 is in charge of the “execution phase” in which the cytoskeleton is broke down, enzymatic DNA fragments, & apoptotic bodies form. It does not cause inflammation, gross lesions, or fibrosis.

    • Necrosis occurs when the cell can’t control its degradation via a loss of membrane potential & ATP generation (mitochondrial injury). It is a messy process in which the cell bursts & causes unwanted sequelae

  • List the factors that influence the rate of autolysis

    • Larger body size, thicker hair coat, higher internal temperature (warm-blooded animals) or environmental temperature, and herbivorous diet increase the rate of autolysis.

  • Describe the differences between autolysis and necrosis

    • Autolysis occurs diffusely after the animal is dead, and thus does not stimulate an inflammatory response.

    • Necrosis occurs in a focal-multifocal pattern to cells/tissues in a still-living animal and stimulates a local tissue reaction (inflammation ± vascular reaction),

  • Describe the gross morphologic features of autolysis

    • Livor mortis: blue discoloration on dependent side of the animal due to gravity & blood pooling

    • Rigor mortis: stiffness 1-6 hours post-mortem, often with gas production & odor

    • Desiccation: drying; occurs instead of autolysis in cold-blooded animals and in late autolysis of warm-blooded animals

    • Gas production/putrefaction: bubbles in tissue, pale viscera, foul odor

    • Imbibition: tissue discoloration

      • Hemoglobin: red staining from lysed RBCs 1-2 days post-mortem

      • Pseudomelanosis: blue-green to black staining from iron sulfide 1-2 days post-mortem

      • Bile: green/yellow staining from duct & gallbladder leakage

  • List the causes and mechanisms of necrosis

    • Causes: disruption in energy supply & disruption in cell membrane → ATP depletion, mitochondrial damage, loss of calcium homeostasis, & oxidative stress

    • Mechanisms: injury via hypoxia, ischemia, or membrane insult → severe membrane damage → influx of Ca++ into the cell → activation of degradative enzymes → loss of membrane potential & ATP generation → necrosis

  • Define the types of oncotic necrosis & describe the pathogenesis

    • Coagulative: proteins accumulate in tissue, causing the tissue architecture to be preserved with minimal inflammation. Caused by local heat, disrupted blood flow, or toxin exposure.

    • Liquefactive: proteolytic enzymes break down tissues resulting in dissolution, causing loss of tissue architecture with prominent neutrophilic inflammation. Typically caused by bacteria & neutrophils.

    • Caseous: tissues are semi-solid/cheesy, granular & friable, and may mineralize, often forming a granuloma (dry necrotic core, layers of neutrophils & macrophages, connective tissue capsule). Typically caused by granulomatous inflammation from persistent pathogens

    • Gangrenous: a progression of coagulative necrosis

      • Wet: + liquefactive & saprophytic bacteria → oozing discharge

      • Dry: + infarction → drying/mummification

      • Gas: + anaerobic bacteria → emphysema/crepitus

  • Define the gross and histologic characteristics of oncotic necrosis

    • Gross: well-demarcated foci w/irregular contours, pallor, & cavitation, often with red or white rim

    • Histologic: loss of cellular detail, hypereosinophilia, nuclear alterations, typically present with a gradient of degenerative cells

  • List the outcomes of necrosis

    • Restoration: stem cells proliferate to restore structure/function

    • Evolution: debris is dehydrated to form a semi-solid core that may mineralize

    • Replacement: scarring/fibrosis

    • Tissue loss: dead cells slough off, another outcome ensues

    • Death: if dead tissue is too large for orderly removal, a sequestrum is formed


Biochemistry Profiles

  • Describe appropriate specimen collection and sample handling

    • Collect 2-3mls blood in red top tube, spin down once coagulated

  • Explain why a normal animal can have an abnormal laboratory result and an animal with disease can have a normal laboratory result

    • RIs created using distribution of animals, include 95% of normal animals, meaning 5% can present with an abnormality despite being normal

    • Overlap of normal and abnormal occurs at edges of range, so some abnormal animals can present normally

  • Explain the differences between pre-analytical, analytical, and post-analytical error and identify which type of error is most common

    • Pre-analytical (most common): made by the vet requesting the test

    • Analytical: made at the lab while running the sample

    • Post-analytical: made while delivering/interpreting the results

  • Explain why laboratory data should be interpreted with signalment, history, physical examination findings, and results of other tests

    • Many normal animals will have an abnormal result, and many abnormal animals will have some normal results. History + PE inform whether the lab results are significant or unlikely to be clinically relevant.

  • Explain how to group tests to assess specific organ systems and disease processes (e.g., kidney, liver, hydration status)

    • Kidney function: BUN, creatinine, phosphorus

    • Liver function: ALT, AST, ALP, bilirubin, BUN, cholesterol, glucose, albumin

    • Electrolyte balance: sodium, potassium, chloride, bicarbonate

    • Hydration status: total protein, globulins, albumin

    • Muscle: CK, AST

  • Explain how blood urea nitrogen (BUN) and creatinine (Cr) (and phosphorus, P) in combination with signalment, history, and other laboratory data (e.g., urine specific gravity) can be used to differentiate pre-renal, renal, and postrenal disorders

    • Pre-renal (dehydration): high USG, increased skin turgor + CRT, tacky MM, increased HCT/TP

    • Renal (Kidney Dz): sometimes low USG

    • Post-renal (urinary obstruction): clinical history, AUS

  • Explain how electrolytes are important in maintaining electroneutrality

    • Balance of cations + anions

  • Identify the primary cellular location for sodium, potassium, and chloride

    • Extracellular: sodium + chloride

    • Intracellular: potassium

  • Interpret common electrolyte changes

    • Hypernatremia: loss of hypotonic fluid (V+/D+)

    • Hyponatremia: extreme diarrhea, bladder rupture

    • Hyperkalemia: kidney Dz

    • Hypokalemia: anorexia, V+/D+

    • Hyperchloremia: fluid loss, metabolic acidosis, kidney Dz

    • Hypochloremia: vomiting (SA), large bowel diarrhea and sweating (equine), displaced abomasum (bovine)

    • High bicarbonate: metabolic alkalosis

    • Low bicarbonate: metabolic acidosis

  • Explain how to assess hepatocellular damage (leakage enzymes), cholestasis (alkaline phosphatase and bilirubin), and synthetic liver function (albumin, glucose, BUN)

    • Hepatocellular damage: increased ALT** (SDH in large) + AST, only relevant w/marked increase (3x upper RI)

    • Cholestasis: increased ALP + bilirubin

    • Synthetic function: decreased BUN, cholesterol, albumin, glucose

  • Explain how to differentiate pre-hepatic, hepatic, and post-hepatic hyperbilirubinemia

    • Pre-hepatic (hemolytic anemia): low HCT, observe serum color (yellow)

    • Hepatic (liver Dz): increase in liver enzymes

    • Post-hepatic (biliary obstruction): enlarged gallbladder on AUS

  • List 2 enzymes used to evaluate muscle

    • AST - product of muscle, heptocyte, and RBC breakdown.

    • CK - muscle specific

  • Describe how serum protein concentration can be used with the PE, CBC, other profile results, and USG to determine if there is dehydration, inflammation, neoplasia, protein loss from the GI tract or urinary tract, or decreased production from liver disease

    • Increased TP (dehydration, inflammation, neoplasia):

      • High USG/increased skin turgor + CRT/tacky MM = dehydration

      • Inflammatory leukogram = inflammation

      • Increased Ig + evidence of multiple myeloma = neoplasia

    • Decreased TP (GI loss, decreased liver production): evaluate other synthetic factors of the liver (glucose, BUN)

  • Explain what an increased lactate can mean

    • Product of anaerobic metabolism (decreased oxygenation of tissues)

    • Can be caused by shock, hypoxemia, too much exercise, anemia, and liver/kidney disease

    • Generally indicates poor prognosis


Accumulations & Deposits

  • Describe the four mechanisms of intracellular accumulations

    • Abnormal metabolism of a normal cellular substance

    • Abnormal endogenous substance due to protein folding/transport defect

    • Lack of enzyme that metabolizes normal endogenous substances

    • Abnormal exogenous substance due to cellular ingestion of indigestible materal

  • Describe hyaline and give examples

    • Hyaline accumulations are homogenous, eosinophilic/pink, and amorphous. They can be found intra- or extracellularly and are non-specific for cellular changes.

    • Ex: resorption droplets of protein, Russell bodies (Ig) in cytoplasm of plasma (Mott) cells

  • Describe the gross and microscopic changes seen with amyloidosis

    • Gross: organs appear firm, pale, waxy, & swollen. Stains black with Lugol’s iodine

    • Microscopic: eosinophilic/pink “cotton candy-like” material accumulating in extracellular spaces. Stains orange/red with Congo Red stain.

  • List the common sites of amyloidosis

    • Always extracellular. Often in/near vascular beds. Commonly seen in kidney (glomeruli), liver (space of Disse), spleen, lymph nodes, & adrenal cortex.

  • Describe the pathogenesis of secondary amyloidosis

    • Chronic inflammation → increased acute phase proteins → release of SAA (amyloid precursor) from liver → misfolding into AA → deposition in tissues

    • Secondary amyloidosis is the majority of cases

  • Outline the pathogenesis of gout

    • Inability to process uric acid + impaired excretion by kidneys OR overproduction (via excess dietary protein & calcium) → high plasma uric acid concentration → monosodium urate crystals on visceral + articular surfaces → chronic inflammation

  • Describe the microscopic and gross changes seen with gout

    • Gross: white chalky deposits on visceral or articular surfaces (tophi)

    • Microscopic: crystals seen as acicular clefts (needle-shaped empty space) & birefringent crystals surrounded by inflammatory cells

  • Differentiate between dystrophic and metastatic calcification and understand the pathogenesis of each

    • Dystrophic: occurs in dead/dying tissues as phosphates release from the cells, forming calcium “soaps” around the central nidus of necrosis

    • Metastatic: occurs in living/healthy tissues secondarily to hypercalcemia, which may result from PTH-like protein secreting neoplasms, vitamin D toxicosis, bone destruction, or renal disease